CLNN Clene Inc.
$3.97▲ +3.39%
ConsumerStaples
Other
Volume 31.3K
Avg Volume (10D) 107.9K
Key Metrics & Fundamentals
Market Cap
$56.43M
P/E Ratio
–
Div Yield
0.00%
52W Range
3.02 - 13.50
% vs 50 MA
0.02%
% vs 200 MA
-23.67%
RSI-14
54.2
MACD Histogram
+0.0700
Beta (1Y vs SPY)
1.83
Free Cash Flow
-$2.59M
Gross Rev
$90,000
Gross Profit
$54,000
EBITDA
-$4.91M
COGS
$36,000
Operating Exp
$5.22M
Operating Income
-$5.16M
EBIT
-$5.16M
Pretax Income
-$13.42M
Net Income
-$13.42M
EPS (Diluted)
-1.08
Price & Volume History
Loading chart…
Recent News
Clene Announces New Drug Application Submission to FDA for CNM-Au8 for the Treatment of ALS
GlobeNewswire · Oct 19, 2026 8:00 AM ET
Clene Targets Q4 FDA Filing for ALS Drug CNM-Au8, Eyes Mid-2027 Decision
MarketBeat · Oct 2, 2026 8:02 AM ET
Clene to Present at Upcoming Investor Conferences
GlobeNewswire · Sep 22, 2026 8:00 AM ET
Clene Announces Closing of $4 Million Registered Direct Offering Extending Capital Runway Beyond FDA Decision on CNM-Au8® NDA
GlobeNewswire · Sep 21, 2026 8:30 AM ET
Top Midday Gainers
MT Newswires · Sep 15, 2026 2:30 PM ET
Clene Announces $4 Million Registered Direct Offering
GlobeNewswire · Sep 15, 2026 9:00 AM ET
Clene to Present at Upcoming September Investor Conferences
GlobeNewswire · Sep 3, 2026 8:00 AM ET
Clene Eyes Q4 NDA for ALS Drug After FDA-Requested Biomarker Analyses
MarketBeat · Aug 19, 2026 6:03 PM ET
Presenting on Emerging Growth Conference 95 Day 1 on August 19; Register to live stream
GlobeNewswire · Aug 18, 2026 7:00 AM ET
Clene to Present at the Emerging Growth Conference
GlobeNewswire · Aug 17, 2026 8:30 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See CLNN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.